The present invention relates to a topical pharmaceutical preparation fortreating an inflammatory skin condition,preferably a condition associated with ischemia, comprising a supernatant of aphysiological solution obtainable by cultivating peripheralblood mononuclear cells (PBMCs) or a subset thereof in a physiologicalsolution free of PBMC-prolif erating andPBMC-activating substances for at least 1 h.